Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-22

Clinical Trial Update: Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for Pemphigus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a combination of immunoadsorption, dexamethasone pulse therapy, and rituximab for pemphigus has completed and posted results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Immunoadsorption
  • Rituximab (rituximab)

Snippet

Sponsor: University of Luebeck | Conditions: Pemphigus | Phase 2 | Status: COMPLETED | Results posted: 2016-12-22